Literature DB >> 6448621

Drug-induced anogenital cicatricial pemphigoid.

T van Joost, W R Faber, H R Manuel.   

Abstract

A case of cicatricial pemphigoid (CP) with a rare primary localization on the mucosal surfaces of the anus and the vulva and on perianal skin, associated with long-term therapy with clonidine, is described. Direct immunofluorescence investigation of lesional skin suggests possible complement mediated tissue injury in between basement membrane and epidermal basal cells. The possibility is discussed that drug induced metabolic disturbance (cyclic AMP-system) at a local level at the site of the basal cells might lead to the formation of immunogens and be one of the initiating factors in subepidermal bullous immune dermatoses. It is concluded that in cases of cicatricial pemphigoid the use of drugs must be considered as one of the aetiological possibilities.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448621     DOI: 10.1111/j.1365-2133.1980.tb06574.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Drug induced bullous eruptions.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

2.  Mefenamic acid-induced bullous pemphigoid.

Authors:  A N Shepherd; J Ferguson; M Bewick; I A Bouchier
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

3.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.